Phase 2a study of BPN14770 in patients with Alzheimer's disease
Phase of Trial: Phase II
Latest Information Update: 06 Nov 2017
At a glance
- Drugs BPN 14770 (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 06 Nov 2017 According to a Tetra Discovery Partners media release, the company anticipates to initiate this trial in the first half of 2018.
- 05 Dec 2016 New trial record
- 29 Nov 2016 According to a Tetra Discovery media release, this trial is expected to initiate during the second half 2017.